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UU and UA dinucleotides are rare in mammalian genes 
and  may  offer  natural  selection  against  endoribonu-
clease-mediated mRNA decay. This study hypothesized 
that  reducing  UU  and  UA  (UW)  dinucleotides  in  the 
mRNA-coding sequence, including the codons and the 
dicodon boundaries, may promote resistance to mRNA 
decay, thereby increasing protein production. Indeed, 
protein expression from UW-reduced coding regions of 
enhanced green fluorescent protein (EGFP), luciferase, 
interferon-α,  and  hepatitis  B  surface  antigen  (HBsAg) 
was  higher  when  compared  to  the  wild-type  protein 
expression. The steady-state level of UW-reduced EGFP 
mRNA  was  higher  and  the  mRNA  half-life  was  also 
  longer.  Ectopic  expression  of  the  endoribonuclease, 
RNase L, did not reduce the wild type or UW-reduced 
mRNA. A mutant form of the mRNA decay-promoting 
protein, tristetraprolin (TTP/ZFP36), which has a point 
mutation in the zinc-finger domain (C124R), was used. 
The  wild-type  EGFP  mRNA  but  not  the  UW-reduced 
mRNA responded to the dominant negative action of 
the C124R ZFP36/TTP mutant. The results indicate the 
efficacy of the described rational approach to formulate 
a general scheme for boosting recombinant protein pro-
duction in mammalian cells.
Received 25 July 2011; accepted 30 January 2012; advance online 
publication 20 March 2012. doi:10.1038/mt.2012.29
IntroductIon
Mammalian mRNA decay is a complex process comprising an 
essential component of transient responses. It is usually controlled 
by cis-acting factors, such as AU-rich elements (AREs) in the 
3′UTR, and transacting factors, such as RNA-binding proteins, 
miRNA, and ribonucleases (reviewed in refs. 1,2). Traditionally, 
the 3′UTR has been viewed as the region most recognized by 
RNA-binding  proteins  such  as  tristetraprolin  (TTP/zfp36)  and 
HuR, and that exoribonucleases largely mediate mRNA decay.3 
Conversely, very few mammalian endoribonucleases are known 
and they were shown to cleave at UA di-ribonucleotides.4,5 One 
endoribonuclease—RNase L—has a substrate cleavage preference 
at UU and UA in single-stranded viral mRNAs during acute viral 
infections and possibly in cellular mRNAs under certain condi-
tions.6–9 Another endoribonuclease has been described that pref-
erentially  cleaves  single-stranded  mRNA-coding  regions  inside 
UA and UG in several mRNAs, including c-myc, MDR1, and 
β-globin.10 Since UA and UU dinucleotides are common targets 
for these known endoribonucleases, we sought to eliminate, or at 
least reduce, UW (W = A or U) dinucleotides in the coding region 
of several genes, without affecting the protein code.
The  UA  dinucleotides  are  generally  under-represented  in 
human and other vertebrate genomes and are further deficient 
in the mRNA when compared to nontranscribed DNA.5 The UA 
dinucleotides occur less frequently in the coding region than in 
the 3′UTR.11 Deficiency of UW frequency in coding regions may 
impose  a  selection  against  endoribonuclease-mediated  mRNA 
decay inside UA dinucleotides.5,11 In this report, we showed that 
mRNA stability increased as a result of reduction in UW  fre-
quency, leading to increased protein production. This observation 
suggests a general approach for rational design of synthetic genes 
to yield robust protein expression.
results
The UW frequency was reduced in synthetic genes by choosing 
alternative codons that do not contain UW, as well as by replac-
ing UW in the dicodon boundary by changing the first codon 
(Figure 1a). This dicodon change completely destroys UU and 
UA  at  boundary  sites.  Several  coding  regions  were  utilized  to 
assess the approach, namely the reporter genes enhanced green 
fluorescent  protein  (EGFP)  and  luciferase  and  the  biotechnol-
ogy related genes interferon-α and hepatitis B surface antigen 
(HBsAg; Figure 1b). The modification resulted in a significant 
reduction of UU dinucleotides (>68%, P < 0.001, χ2-test). The UA 
and, to a lesser extent, AU dinucleotides were reduced as a result 
of the sequence modification, whereas GA dinucleotide frequency 
(used as a control) did not decrease (Figure 1b). The mammalian 
expression vectors harboring these sequences were cotransfected 
with red fluorescent protein plasmid into the HEK293 cell line, 
and then the protein expression levels were assessed in compari-
son to unmodified sequences (Figure 1c). There was increased 
protein expression (five- to eight-fold) from expression constructs 
with UW-reduced coding regions. When inserted, with red flu-
orescent protein plasmid also, into the CHO1 cell line, which is 
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a biotechnology standard cell line, the modified expression cas-
settes also gave higher protein expression (Figure 1d). Thus, the 
data demonstrate that UW reduction in coding regions leads to 
higher protein expression.
In order to evaluate the effect of sequence modification on 
DNA uptake as a factor in transfection efficiency, we cotransfect 
the  different  expression  vectors  with  a  rhodamine-conjugated 
linear  polyethylenimine  derivative.  We  found  no  statistically 
significant difference in DNA uptake between the wild type and 
the sequence modified UW-reduced constructs (Supplementary 
Figure S2). A marginal significance (P = 0.06) was observed for 
the UW-reduced HBsAg construct, but this small increase (19% 
increase) played only a little role in the substantial increase in pro-
tein expression (400%, Figure 1c). The polyethylenimine-medi-
ated transfection of WT and UW-reduced EGFP gave comparable 
results to liposomal-mediated transfection in that UW-reduced 
EGFP showed increased expression (Supplementary Figure S1).
Next,  we  focused  on  EGFP  so  that  we  could  study  both 
mRNA and protein expression (by fluorescence). A representa-
tive image of WT EGFP and UW-reduced EGFP shows a dra-
matically enhanced fluorescence, whereas no increase is shown 
for the cotransfected red fluorescent protein,plasmid (Figure 2a 
and b). Expression of the UW-reduced luciferase-coding region 
under conditions of low amounts of transfected DNA (10 ng/well) 
was higher when compared to 75 ng/well (Figure 2c). The data in 
Figure 2 and Supplementary Figure S2, taken together, indicate 
that the enhancing effects of UW reduction on protein expres-
sion are not related to preferential DNA uptake or to variations in 
transfection efficiency.
Furthermore, we have examined the mRNA half-life changes 
due to the UW sequence reduction. We employed the one-phase 
exponential decay model which describes kinetics in which the 
levels of a substance never decay to zero but reach a plateau. 
This is the case of our mRNA decay curves here, which fit the 
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Figure 1  Impact of UW dinucleotide frequency on protein expression. (a) The dicodon change algorithm eliminates UU or UA at the boundary 
by replacing the first amino acid codon that ends with U with a synonymous codon that ends with an S nucleotide. X is any amino acid. S (G or C), 
M (A or C), R (A or G) nucleotides are IUPAC symbols. (b) Dinucleotide frequency analysis in WT and UW reduced mRNA-coding region constructs. 
The Compseq program, an EMBOSS algorithm29 that calculates nucleotide composition in a sequence, was used http://mobyle.pasteur.fr/cgi-bin/
portal.py#forms::compseq. The expected frequency of any dinucleotide is 1/16 (6.25%). Thus, the observed to expected ratio = % observed dinucle-
otide/6.25%. The observed dinucleotide (%) is shown on the columns. Several coding regions were designed based on the algorithm shown in figure. 
These were custom synthesized, and then subcloned into expression vectors. Two cell lines (c) HEK293 or (d) CHO1 were cotransfected with expression 
vectors containing wild-type (WT) coding region or UW-reduced coding region (UWr) of different genes and red fluorescent protein (RFP) plasmid at a 
ratio of 1/4. Protein expression at 18 hours after transfection was quantified by fluorescence (EGFP), chemiluminescence (luciferase), or enzyme-linked 
immunosorbent assay (ELISA) [interferon-α (IFN-α) and hepatitis B surface antigen (HBsAg)]. Data are presented as RFP-normalized fold increase which 
= (Expression values of UWr plasmid/WT plasmid) × (RFP normalization ratio). Data are mean ±SEM of three independent experiments.956  www.moleculartherapy.org  vol. 20 no. 5 may 2012              
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model with superior goodness of fit (R2 ≥ 0.95). Also, others’ 
work applied the one-phase exponential decay model on mRNA 
  kinetics that behaves in a manner where decaying mRNA levels 
do not reach zero but a plateau.12–16 We found that the mRNA for 
the UW-reduced EGFP had a longer half-life (2.5–3-fold increase, 
P = 0.01, F-test) compared to the WT mRNA, indicating that UW 
frequency reduction led to mRNA stabilization (Figure 3a). It is 
generally known that such a modest degree of mRNA half-life 
increase can lead to a substantial enhancement of protein expres-
sion. Steady-state mRNA levels were also higher (2.75-fold, P < 
0.05) when expressed from the UWr-EGFP construct compared 
to  the  wild-type  unmodified  EGFP  DNA  (Figure  3b).  When 
EGFP and UWr-EGFP-coding regions were fused with 3′UTR 
that contained ARE from the unstable tumor necrosis factor-α 
mRNA, higher protein expression was observed from the UWr-
EGFP  construct  compared  to  the  WT  EGFP  (32-fold  versus 
8-fold, P < 0.001; Figure 3c). In general, under conditions of low 
mRNA expression, transgene expression usually correlated posi-
tively with protein expression.17
In order to understand the mechanism of increased mRNA 
stability due to UW reduction in coding regions, we first inves-
tigated the involvement of RNase L by overexpression and small 
interfering  RNA  experiments.  We  found  that  overexpression 
of HA-tagged RNase L did not reduce mRNA stability of either 
EGFP  or  UWr-EGFP  (Figure  4a,b).  Western  blotting  demon-
strate expression of transfected RNase L by probing with anti-
body to the HA tag (Figure 4a,b; insets). At the protein level, we 
also noted that RNase L did not reduce the levels of WT or UWr 
EGFP, although there was a slight increase in WT EGFP expres-
sion (Figure 4c). Hence, in general, we found either no effect or 
an inconsistent effect of RNase L overexpression or of treatment 
with a small interfering RNA to RNase L (data not shown). We 
therefore resorted to another strategy that utilized the C124R zinc 
finger mutant form of TTP (TTP/ZFP36).
The TTP binds to AREs as small as UAUUUAU18,19 and the 
C124R mutant fails to bind to AREs.20 However, C124R can still 
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Figure 2  effect of sequence modification and normalization on dnA uptake and expression. (a) Representative image showing green (G), red 
(R; red fluorescent protein (RFP) plasmid normalization plasmid), and superimposed GR channels. (b) HEK293 cells were cotransfected with green 
fluorescent protein (GFP) (100 ng) and RFP (25 ng) expression plasmids. The fold ratio changes between the expression levels as a result of WT 
and UWr-coding region modification are shown (mean ± SEM) for three independent experiments. (c) HEK293 cells (3 × 104 cells/well) in 96-well 
microplates were cotransfected with RFP expression plasmid and expression vectors containing either the WT-coding region or the UWr-coding region 
using low DNA input (10 ng/well) or high DNA input (75 ng/well).
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Figure  3  mrnA  stability  and  uW  reduction.  (a)  Half-life  mRNA 
determinations of the two enhanced green fluorescent protein (EGFP) 
mRNA sequence variants. HeLa Tet-off cell line was transfected with 
the  indicated  expression  vectors,  and  transcriptional  activity  was 
blocked by doxycycline (1 μg/ml). RNA was extracted at the indicated 
points and subjected to reverse transcription (RT)-QPCR. The one-
phase decay model7 was used to quantify the half-life for WT and UW-
reduced (UWr) EGFP mRNAs; R2 = 0.96 and 0.95, respectively. Data are 
average of two experiments (mean ± SEM); each with three replicates. 
(b) The steady state mRNA levels of WT and UW-reduced EGFP-coding 
region expression. (c) The EGFP variants were expressed from cod-
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interact with a number of general mRNA decay enzymes such 
as those involved in deadenylation (e.g., Caf1), decapping, and 
exonuclease activity.17 Hence, the nonbinding mutant TTP can 
sequester general mRNA decay factors.17,18 This dominant nega-
tive activity appears to be specific to the 3′UTR-ARE at lower con-
centrations, but we hypothesized that it may have broader effects 
at higher concentrations in a manner independent of the 3′UTR. 
Thus, we overexpressed C124R TTP in Hela Tet-off cell line and 
studied the effects on UW-reduced EGFP mRNA and wild-type 
mRNA.  Western  blotting  confirmed  expression  of  the  trans-
fected C124R TTP (Figure 4d,e insets). The mRNA half-life was 
assessed for both WT EGFP and UWr EGFP transcripts released 
from constructs under regulation of Tet-off cytomegalovirus pro-
moter. The dominant negative effect of C124R TTP, as demon-
strated by mRNA stabilization, was clearly observed in the case of 
the response of WT EGFP mRNA turnover (Figure 4d). Further 
increases in UWr EGFP mRNA stabilization were not observed 
as a consequence of the dominant negative effect of C124R TTP 
(Figure  4e).  Subsequently,  no  increase  in  protein  production 
(fluorescence) from UWr EGFP mRNA was observed in response 
to the dominant negative effect of C124R (Figure 4f, middle col-
umns). In contrast, wt EGFP protein levels were affected by the 
stabilizing effect of C124R on WT EGFP mRNA (Figure 4f, left 
columns).  In  addition  to  tumor  necrosis  factor-α  mRNA,20,21 
C124R TTP (but not wild-type TTP) has been shown recently to 
increase an array of AU-rich mRNAs such as uPA, uPA receptor, 
NF-kappa B inhibitor, matrix metalloproteinase-1, and interleu-
kin-10.22 The C124R has the ability to increase protein expression 
from UWr EGFP transcripts only when the UWr EGFP-coding 
region is fused with ARE-3′UTRs, such as those of tumor necrosis 
factor-α (Figure 4f, right columns). This aspect may lead to an 
improved use of UW-reduced reporter genes such as EGFP and 
luciferase, which is post-transcriptional effect of gene expression 
specific to the 3′UTR.
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Figure 4  response of the enhanced green fluorescent protein (eGFP)-coding region variants to rnase l and dominant negative zinc-finger 
mutant, c124r tristetraprolin (ttP). HeLa Tet-off cell cells (3 × 104 cells/well) in 96-well microplates were cotransfected with expression vectors 
containing (a) wild-type (WT) coding region or (b) UW-reduced coding region (UWr) for EGFP mRNA and each of RNase L or pcDNA3.1 control 
expression vector. Subsequently, the transcription from the cotransfected EGFP plasmid was blocked by doxycycline (1 μg/ml) for the indicated peri-
ods of time. Total RNA was extracted and subjected in reverse transcription (RT)-QPCR using TaqMan primers specific to WT and UWr EGFP mRNA 
(details in Materials and Methods). The one-phase exponential mRNA decay model7 was used to quantify the mRNA half-life for WT (R2 = 0.96 and 
0.99 for vector and RNase L curves) and UW-reduced EGFP mRNAs (R2 = 0.9 and 0.85, vector and RNase L, respectively). The data are mean ± SEM 
of replicate from one representative experiment of two. Insets show Western blotting for transfected HA-tagged RNase L (HA-RL) expression using 
a specific antibody to HA tag. (c) Protein expression changes as a result of RNase L expression using fluorescence level ratio of green fluorescence 
to red fluorescence. Details of experiment are similar to those described in legend A and B. (d,e) HeLa Tet-off cells (3 × 104 cells/well) in 96-well 
microplates were transfected for 18 hours with expression vectors containing (d) wild-type (WT) coding region or (e) UWr-coding region for EGFP in 
the presence of C124R expression vector or pcDNA3.1 control vector. Subsequently, the transcription was blocked by doxycycline (1 μg/ml) for the 
indicated periods of time. The one-phase exponential mRNA decay model7 was used to quantify the mRNA half life for WT (R2 = 0.97 and 0.99 for 
vector and C124R, respectively) and UWr EGFP mRNAs (R2 = 0.96 and 0.9.5 for vector and C124R, respectively). The data are mean ± SEM of three 
replicates from one representative experiment of two independent experiments performed. Insets show Western blotting for C124R expression. (f) 
Protein expression from WT EGFP-coding region, UWr EGFP-coding region, and UWr EGFP-coding region fused with tumor necrosis factor (TNF)-α 
ARE 3′UTR. Data is presented as fluorescence levels (mean ± SEM) of three independent experiments, each with three to four replicates. WT EGFP 
+ pcDNA3.1 vector control was normalized to 1.0-fold ratio. The UWr EGFP and UWr EGFP+ARE data were normalized to UWr EGFP + pcDNA 3.1 
control (fold ratio = 1.0).958  www.moleculartherapy.org  vol. 20 no. 5 may 2012              
© The American Society of Gene & Cell Therapy
UW Frequency Reduction Increases mRNA Stability
dIscussIon
The present approach differs from the classical codon optimiza-
tion that depends on species-specific bias of codon usage, and it 
is thought to be a natural selection for translational optimization. 
This served as the basis for improving overexpression of proteins 
in host cells of a different species.23–25 Our approach is different: 
first, unlike classical codon bias optimization, both codon and 
dicodon boundaries are considered here. Second, this rationalized 
approach is based on reduction of UW dinucleotides; these dinu-
cleotides are rare in mammalian coding regions and have been 
shown to correlate with accelerated mRNA decay.4,5 Our approach 
has  led  to  increased  mRNA  stabilization  and,  subsequently, 
increased  protein  expression  levels.  However,  other  possible 
post-transcriptional effects, such as translation, are likely to take 
part as well. Validation of this role of modification on translation 
efficiency would require a different set of experiments. The very 
modest increase (for example, a 14% increase) in mRNA stability 
observed with classical codon optimization26 may possibly be due 
to an inherited partial UW reduction. For example, the preferred 
human codon for isoleucine is AUC rather than AUU or AUA.
Overall, by resisting mRNA decay using reduced UW frequency 
and elimination of UW in dicodon boundaries, this rationalized 
approach may find utility as a general method to boost recombi-
nant protein production in mammalian cells. The UW reduction 
approach  may  find  broader  applications  if  confirmed  in  other 
expression systems, such as those based on bacterial and insect cells. 
Also, the approach remains to be tested with stable cell lines express-
ing the UW-reduced coding regions, as unlike transient transfec-
tion, potential regulatory mechanisms such as DNA methylation 
may adversely affect stable transgene expression. The approach can 
enhance reporter genes for difficult to transfect cells or can be used 
to study 3′ UTR-mediated post-transcriptional effects due to insta-
bility sequences, such as AREs, or miRNA action.
MAterIAls And Methods
Synthetic  biology.  Coding regions of EGFP, luciferase, interferon α2a, 
and  HBsAg  were  modified  according  the  following  algorithm:  (i)  by 
exchanging UW-containing codons with synonymous codons that lack 
or  reduce  UW ( Supplementary  Table  S1)  and  (ii)  by  destroying  the 
UW dicodon boundary by exchanging the first codon with synonymous 
codons (Supplementary Table S2). The modified coding region sequences 
(Supplementary Table S3) were synthesized by GeneArt (Regensburg, 
Germany) and all constructs, including wild-type coding regions, were-
subcloned using SalI and BamH1 sites in the same vector (Gwiz; Genlantis, 
San Diego, CA). The vector is expressed under control of the cytomega-
lovirus/intron A promoter and with the stable bovine growth hormone 
3′UTR. Cloning of the ARE derived from the tumor necrosis factor-α 
mRNA 3′UTR was previously described.27 Dinucleotide frequency analy-
sis was executed by the Compseq program, an EMBOSS algorithm29 that 
calculates nucleotide composition in a given sequence (http://mobyle.pas-
teur.fr/cgi-bin/portal.py#forms::compseq).  The  formula  of  observed  (0) 
over expected (e) frequency ratio is as follows: (XY o/e = dXY/nX·nY, where 
nX denotes the frequency of nucleotide X, and dXY is the frequency of the 
dinucleotide (XY).
Cell lines and transfection. The HEK293 and CHO1-K cell lines were 
obtained from American Type Culture Collection (Rockville, MD) and 
cultured in DMEM medium (Invitrogen, Carlsbad, CA) or DMEM/F12 
(in case of CHO1-K) supplemented with 10% FBS and antibiotics. The 
Tet-off Hela cell line, obtained from Clontech (Mountain View, CA), was 
maintained in DMEM with selection drug G418 (Sigma, St Louis, MO). 
Cells  were  transfected  with  vectors  using  lipofectamine  2000  reagent 
(Invitrogen) according to the manufacturer’s instructions. All transfections 
were performed in   several replications, and our intrawell transfection effi-
ciency was <6% variation. The red fluorescent protein expression vector 
(Evrogen, San Diego, CA) was used at ¼ ratio of the test plasmid con-
centration for the purpose of normalization. For RNA experiments, EGFP 
(50 ng per 1 × 105 cells) was used for monitoring transfection efficiency.
Quantification of protein expression and western blotting. EGFP expres-
sion  was  assessed  and  quantified  by  fluorescence  imaging  (described 
below). Luciferase expression was assessed using the luciferase assay sys-
tem from Promega (Madison, WI) and a luminometer. Interferon-α and 
HBsAg was quantified by enzyme-linked immunosorbent assay (ELISA) 
obtained from PBL (Piscataway, NJ) and Abzyme (Piscataway, NJ).
For transfected cells with C124R TTP expression vector (a gift from 
Dr Perry J. Blackshear, NIH, US) and HA-tagged RNase L expression 
vector (synthesized by GeneArt), western blottings were performed to 
confirm the protein expression from the vectors. Equal amounts of protein 
samples were subjected to electrophoresis on 10% polyacrylamide–SDS 
gels (Protogel; National Diagnostics, Atlanta, GA) followed by transfer 
to  nitrocellulose  membranes  (Hybond  ECL;  Amersham  Biosciences,   
Piscataway,  NJ).  Membranes  were  hybridized  with  primary  antibody 
to  goat  anti-TTP  (1/500)  (Santa  Cruz  Biotech,  Santa  Cruz,  CA),  rat 
anti-HA A (1/50) (Roche, Basel, Switzerland), or mouse anti-GAPDH 
(1/500; Abcam, Cambridge, UK) followed by the appropriate secondary 
horseradish  peroxidase-conjugated  antibody.  Signal  detection  was 
performed  with  ECL  Western  blotting  detection  reagents  (Amersham 
Biosciences, Amersham, UK). Protein molecular weight markers were 
used to verify the protein size.
Reporter fluorescence, normalization, imaging, and quantitation. The 
fluorescence intensity was assessed using high-resolution images obtained 
from an automated laser-focus high-throughput BD Pathway 435 imager 
(BD Biosciences, San Jose, CA). The variance in GFP fluorescence among 
replicate microwells was <6%. The experiments were normalized with red 
fluorescent protein plasmid at ¼ ratio of the test plasmid concentration. 
Image  processing,  segmentation,  and  fluorescence  quantification  were 
facilitated by the ProXcell program previously described.28 Fluorescence 
of EGFP (excitation, 488 nm; emission, 507 nm) and red fluorescent pro-
tein (excitation, 553 nm; 574 nm) was processed with appropriate filters of 
the BD imager. Data are presented as mean ± SEM of total fluorescence 
intensity in each well, with replicate readings ranging from three to four, as 
indicated in the text. The Student t-test was used when comparing two data 
groups, while analysis of variance was performed for each data set having 
three or more data groups.
DNA uptake. The rhodamine-conjugated linear polyethylenimine deriva-
tive (excitation at 550 nm; emission at 575 nm) was used to assess the 
uptake of DNA by the wild type and modified plasmids. Cells were trans-
fected with a complex of 0.75 µl of jetPEI-FluoR (Polyplus, Paris, France) 
and 200 ng of the plasmid DNA. After 18-hour incubation, the cells were 
visualized by automated fluorescence microscopy and the fluorescence 
quantified as described above. This protocol was also repeated in the pres-
ence of the lipofectamine 2000 to assess its compatibility during liposomal 
transfection and was found compatible.
RNA, reverse transcription, and real-time PCR. Total RNA was extracted 
with  Trireagent  (Sigma).  Reverse  transcription  was  performed  using 
200 ng total RNA, 500 ng oligo dT(18–23), 500 mmol/l dNTP mixture, 
20 U RNAsin (Pharmacia, Milton Keyries, UK), and 200 U of SuperScript 
II (Invitrogen). Real-time PCR was performed using custom-made primer 
sets (Applied Biosystems, Foster City, CA) and TaqMan master mix accord-
ing to the manufacturer’s instructions. The 6-carboxyfluorescein-labeled 
TaqMan  hybridization  probes  were  designed  to  target  the  junction  of Molecular Therapy  vol. 20 no. 5 may 2012  959
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Exons 1 and 2 of EGFP or UWr EGFP to minimize DNA contamination. 
The primer set for EGFP: forward CTCCATCTTCGCGGTAGCT, reverse 
TTCTTCTCCTTTGCTAGCCATTTCT,  probe:  CCGCCGTTCAGTCG 
CCGT. The primer set for UWr EGFP: forward CTCCATCTTCGCGG 
TAGCT,  reverse  CCATGGTGGCAAGCTTGTC,  Probe:  CCGCCGTT 
CAGTCGCCGT.  As  internal  control,  we  used  a  VIC-labeled  GAPDH 
mRNA probe (Applied Biosystems). The primer sets failed to amplify vec-
tor DNA (negative control) and were specific for the complementary DNA. 
PCR protocol was as follows: Initiation steps: 2 minutes at 50 °C followed 
by 10 minutes at 95 °C, denaturing step: 15 seconds at 95 °C, and anneal-
ing/extension 1 minute at 60 °C. The amounts of molecules of complemen-
tary DNA were calculated using Chroma 4 DNA Engine cycler (Bio Rad, 
Hercules, CA) software and an eight-point standard curve using serial dilu-
tions of purified and quantified amplicon DNA. The use of standard curve 
method ensures that all amplifications proceed with a comparable and high 
efficiency. The variations in GAPDH levels in one experiment were typically 
<10%. The lowest internal control measurement was set as 1 fold and the 
copy number of the WT EGFP and UWr EGFP were normalized.
The mRNA half-life determinations. HeLa Tet-off cells were cotransfected 
with TetO-regulated WT or UWr EGFP constructs, along with vector, 
C124R TTP, or RNase L expression vector overnight, and then treated with 
doxycycline (1 μg/ml) to shutoff transcription. The RNA was extracted 
by the RNAzol method at multiple points and then subjected to reverse 
transcription-QPCR as described above. To ensure equal proportions of 
transfected cells for each time point, cotransfections were performed in 
10-cm culture plates using 4 μg of the vector DNA, and 24 hours later 
the cells were split into 6-well plates. The mRNA half-life was determined 
using a one-phase exponential decay model. The equation Y = Span × 
exp(–K × X) + Plateau describes the kinetics of mRNA decay. X is time, 
and Y depicts the response. Y starts out equal to SPAN + PLATEAU and 
decreases to PLATEAU with a rate constant K. The half-life of the decay is 
0.6932/K. SPAN and PLATEAU are expressed in the same units as the Y 
axis. K is expressed in the inverse of the units used by the X axis. Data fit 
to the model was performed using Least Squares fit method. Comparison 
between mRNA curves was performed using an F-test.
suPPleMentArY MAterIAl
Figure S1.  Expression  of  WT  and  UWr  EGFP  after  PEI-mediated 
transfection.
Figure S2.  Effect of sequence modification on DNA uptake.
Table S1.  UU/UA reduction in codons.
Table S2.  UU/UA elimination in di-codon boundaries.
Table S3.  UW-reduced sequences.
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